Keywords: Metformin; Acute leukemia; mTOR; AMPK; Adjuvant chemotherapy;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Akt; protein kinase B; AL; ad labitum; BDNF; brain-derived neurotrophic factor; CR; caloric restriction; LC3; microtubule-associated protein 1 light chain 3; mTOR; mammalian target of rapamycin; MWM; Morris water maze; OFT; open field test; PI3K; phosphat
Keywords: Protein synthesis; Protein breakdown; mTOR; Amino acids;
Keywords: ACE; angiotensin-converting enzyme; ANF; atrial natriuretic factor; BNP; brain natriuretic peptide; DCM-CD; dilated cardiomyopathy with conduction defects; EDMD; Emery-Dreifuss muscular dystrophy; EHT; engineered heart tissue; KI; knock-in; KO; knock-ou
Keywords: EGFR; epidermal growth factor receptor; NSCLC; non-small cell lung cancer; TKI; tyrosine kinase inhibitor; WT; wild type; KRAS; Kirsten RNA associated rat sarcoma 2 virus gene; PTEN; phosphatase and tensin homolog; HGF; hepatocyte growth factor; IGF1R; in
Keywords: AMPK; central nervous system; energy balance; glucose homeostasis; hypothalamus; lipid metabolism; mTOR; thyroid hormones
Keywords: AKT; protein kinase B; CAV-3; caveolin-3; Cyt c; cytochrome c; eNOS; endothelial nitric oxide synthase; ERK1/2; extracellular signal-regulated kinase 1/2; GRK2; G-protein coupled receptor kinase 2; GSK3β; glycogen synthase kinase 3β; MEK; MAPK/ERK kinas
Keywords: HIFs; hypoxia inducible transcription factors; pO2; oxygen pressure; HREs; hypoxia responsive elements; PHD; prolyl hydroxylase domain-containing protein; FIH; factor inhibiting HIF; pVHL; von Hippel-Lindau tumour suppressor; mTOR; mechanistic target of r
Keywords: Abs; antibodies; Akt; cytoplasmic serine-threonine kinase from Ak mouse strain thymoma; Cbl; cobalamin; Cbl-D; Cbl-deficient; CNS; central nervous system; CSF; cerebrospinal fluid; DMSO; dimethyl sulfoxide; Dpl; Doppel; EGF; epidermal growth factor; GFAP;
Keywords: ANOVA; analysis of variance; ATF-4; activating transcription factor-4; ATF-6; activating transcription factor-6; C/EBP; CCAAT/enhancer-binding protein; CHOP; C/EBP homologous protein; eIf2α; eukaryotic translation initiation factor 2 subunit α; ER; endo
Keywords: Diabetes; Cancer; Insulin; Anti-diabetics; Cannabinoid; Obesity; 2-AG; 2-arachidonoyl glycerol; ACC; acetyl-CoA carboxylase; AMPK; adenosine monophosphate-activated protein kinase; CB1R; cannabinoid 1 receptor; CB2R; cannabinoid 2 receptor; CPT-1; carniti
Keywords: AC; adenylyl cyclase; ALDH; aldehyde dehydrogenase; ANT; adenine nucleotide transporter; AR; adrenergic receptor; ARE; antioxidant response element; ATP; adenosine triphosphate; cAMP; cyclic adenosine monophosphate; COX; cyclo-oxygenase; CsA; cyclosporine
Keywords: Mitochondria; Mitochondrial diseases; Neurodegenerative disorders; Pharmacological neuroprotection; Mitochondrie; Maladies mitochondriales; Maladies neurodégénératives; Neuroprotection pharmacologique; AD; Alzheimer's disease; AICAR; 5-aminoimidazole-4
Keywords: Aβ; amyloid β protein; NFT; neurofibrillary tangles; APP; amyloid precursor protein; PSs; presenilins; NICD; Notch intracellular domain; mTOR; mammalian Target of Rapamycin; PP2A; protein phosphatase 2; GSK-3; glycogen synthase kinase-3; CTFS; cytosol-s
Keywords: mTOR; rapamycin; seminiferous tubule culture; STRA8;
Keywords: ALDH2; aldehyde dehydrogenase 2; ANT; adenine nucleotide transportor; AR; aldose reductase; AMPK; AMP-activated protein kinase; ATF6; activating transcription factor 6; ATG; AuTophaGy; ATM; ataxia-telangiectasia mutate; COPD; chronic obstructive pulmonary
Keywords: Retinal light injury; Endoplasmic reticulum stress; Neuroprotection; mTOR; Rapamycin; Photoreceptor cell
Keywords: 4E-BP; 4E binding protein; AP-1; activator protein-1; Ad-AH; EBV-negative adenocarcinoma cell line; Akt; serine/threonine kinase; ARNT; aryl hydrocarbon receptor nuclear translocator; ATP/ADP; adenosine tri- or diphosphate; CAIX and CAXII; carbonic anhydr
Keywords: AIF; apoptosis-inducing factor; AMPK; AMP kinase; Apaf-1; apoptotic protease activating factor; BMM; bone marrow-derived macrophages; cFLIP; cellular FLICE-like inhibitory protein; cIAP; cellular inhibitor of apoptosis protein; COX; cyclooxygenase; CTL; c
Keywords: ESFT; Ewing's sarcoma family tumors; ES; Ewing's sarcoma; MCTS; multicellular tumor spheroids; 3D; three-dimensional; PCL; poly(ε-caprolactone); ECM; extracellular matrix; PDX; patient-derived tumor explants; MSC; mesenchymal stem cells; EC; endothelial
Keywords: VEGF; vascular endothelial growth factor; CRC; colorectal cancer; VEGFR; VEGF receptors; PLGF; placental growth factor; HGF; hepatocyte growth factor; Il; Interleukin; Del-1; developmentally-regulated endothelial cell locus 1 protein; FGF; fibroblast grow
Keywords: Aβ; amyloid-β; AD; Alzheimer's disease; ALP; autophagy-lysosome pathway; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; ApoER2; apolipoprotein E receptor 2; APP; Aβ precursor protein; BDNF; brain-derived neurotrophic factor; CSF; cere
Keywords: AA; arachidonic acid; ADP; adenosine diphosphate; AIF; apoptosis-inducing factor; AMPK; AMP-activated protein kinase; ANT; adenine nucleotide translocase; Apaf-1; apoptotic protease activating factor-1; ATP; adenosine triphosphate; ATP-ase; ATP synthase;
Keywords: Autophagy; Natural compounds; mTOR; Hepatic stellate cells; Liver fibrosis;
Keywords: 5FU; 5-fluorouracile; ABC; ATP-binding cassette; AUC; area under the curve; BCRP; breast cancer resistance protein; Cmax; maximum (peak) plasma concentration; CYP; cytochrome p450 enzymes; DDI; drug-drug interactions; EIAEDS; enzyme-inducing antiepilept
Keywords: AL; ad libitum; BAP; Biomarkers of Aging Program; CR; caloric restriction; EM; Emory-Morse; GSH; glutathione; GSSG; glutathione disulfide; mTOR; mammalian target of rapamycin; NCTR; National Center for Toxicological Research; NIA; National Institute on Ag
Keywords: Senolytic; an agent that targets senescent cells; ADME; absorption, distribution, metabolism, and excretion of a drug; SASP; senescence-associated secretory phenotype; mTOR; mammalian target of rapamycin; JAK; Janus-activated kinase; GLP; good laboratory
Keywords: CRC; colorectal cancer; IACR; International Agency for Cancer Research; AMPK; adenosin monophosphate-activated protein kinase; mTOR; mammalian target of the rapamycin; Nampt; nicotinamide phosphoribosyltransferase; PBEF1; pre-B cell-colony enhancing facto
Keywords: BMI; body mass index; CRP; C-reactive protein; db/db; diabetic; ER; endoplasmic reticulum; HSP; heat shock proteins; JAK; janus kinase; ob/ob; obese; LEPR; leptin receptor; MAPK; mitogen-activated protein kinase; mTOR; mammalian target of rapamycin; NK; n
Keywords: cAMP; cyclic adenosine monophosphate; mTOR; mammalian target of rapamycin; EGFR; epidermal growth factor receptor; ERK; extracellular-signal-regulated kinases; ADPKD; Berberine; Cell proliferation; ERK and p70-S6 signaling; Apoptosis;
Keywords: Epilepsy; Metabolism; Dietary treatments; Ketogenic diet; Calorie restriction; 2-deoxy-d-glucose; mTOR; Anaplerosis;
Keywords: LT; liver transplantation; MC; Milan Criteria; HCC; hepatocellular carcinoma; CNI; calcineurine inhibitor; mTOR; mammalian target of rapamycin; UP; untreatable presentation/progression; BSC; best supportive care; AE; adverse event; CTCAE; common terminolo
Keywords: MDD; major depressive disorder; PFC; prefrontal cortex; BA 10; Brodmann's area 10; mTOR; mammalian target of rapamycin; GC1; mitochondrial glutamate carrier 1; NRP-1; neuropilin 1; GRINA; glutamate receptor ionotropic N-methyl-d-aspartate-associated prote
Keywords: AKT; a serine/threonine-specific protein kinase, also known as Protein Kinase B (PKB); CCS; charcoal-stripped fetal-calf serum; CSC; cancer stem cell; E2; 17β-estradiol; E2:ER; E2-bound estrogen receptor; EGFR; epidermal growth factor receptor; ER; estro
Keywords: IS; immunosuppression; CNI; calcineurin inhibitor; HCV; hepatitis C virus; RCT; randomized clinical trial; ATG; anti-thymocyte globulin; MMF; mofetil mycophenolate; mTOR; mammalian target of rapamycin; RISET; reprogramming the immune system for the establ
Keywords: LT; liver transplantation; CNI; calcineurin inhibitors; LD; low-dose; SD; standard-dose; HCV; hepatitis C virus; LFT; liver function test; MMF; mycophenolate mofetil; mTOR; mammalian target of rapamycin; HBV; hepatitis B virus; Biopsy; Graft rejection; Im
Keywords: BM; basement membrane; ECM; extracellular membrane; EMT; epithelial mesenchymal transition; FAK; focal adhesion kinase; MAPK; mitogen-activated protein kinase; LOH; loss of heterozygosity; NCOR1; nuclear receptor co-repressor 1; MMP; matrix metalloprotein
Keywords: dystonia; striatum; dopamine; signal transduction; GNAL/Gα(olf); mTOR;
Keywords: 15-F2t-IsoP; 15-F2t-isoprostane; ADP; adenosine 5ʹ-diphosphate; Arg-1; arginase-1; BCAAs; branched-chain amino acids; BME; basal Eagle's medium; IGF-1; insulin-like growth factor-1; IL; interleukin; iNOS; inducible nitric oxide synthase; KPBS; potassium-
Keywords: HFD; High fat diet; LFD; Low fat diet; Insulin; Amygdala; hypothalamus; Akt; mTOR; PKCθ;
Keywords: Anti-angiogenesis; Resistance; Targeted therapies; Predictive markers; Autophagy; AKT/PKB; protein kinaseB; BMDCs; bone marrow-derived cells; BVZ; bevacizumab/Avastin; CSC; cancer stem-like cells; EGF; epidermal growth factor; EPC; endothelial progenitor
Keywords: IGF-1; insulin-like growth factor-1; LID; liver IGF-1 deficiency; WT; wild type; FFA; free fatty acid; 3-MA; 3-methyladenine; GH; growth hormone; mTOR; mammalian target of rapamycin; DMEM; Dulbecco's modified Eagle's medium; FBS; fetal bovine serum; P
Keywords: Carotid stenosis; Cell adhesion; Cell surface markers; Gene expression; Immunophenotyping; Mononuclear cells; Thrombosis; ATF; atrial fibrillation; BP; blood pressure; BMI; body mass index; CV; cardiovascular; CEA; carotid endarterectomy; CDP; carotid dis
Keywords: TNF-α; NF-κB; mTOR; Multiple myeloma;
Keywords: FOXO; forkhead box O; GC; glucocorticoids; MuRF-1; muscle RING-finger protein-1; mTOR; mammalian target of rapamycin; IGF-I; Insulin-like Growth Factor-I; eIF4E; eukaryotic translation initiation factor 4E; S6K1; ribosomal protein kinase 1; 4E-BP1; eukary
Keywords: CLX6; Calix[6]arene; CDKs; cyclin-dependent kinases; RB; retinoblastoma; PIM; proviral integration site for the moloney murine leukemia virus; AXL; tyrosine-protein kinase receptor UFO; Mer; tyrosine-protein kinase receptor; PI3K; phosphoinositide 3-kinas
Keywords: 3â²UTR; 3â² untranslated region; Ago2; Argonaute 2; CCN5; cysteine-rich 61/connective tissue growth factor/nephroblastoma overexpressed 5; ChIP; chromatin immunoprecipitation; CUL2; cullin2; DGCR8; Di George syndrome critical region 8; DMNT; DNA methylt
Keywords: LKB1; liver kinase B1; AMPK; AMP-activated protein kinase; mTOR; mammalian target of rapamycin; ULK1/2; unc-51-like kinase1/2; FIP200; focal adhesion kinase family-interacting protein of 200Â kDa; PI; phosphatidylinositol; LC3; microtuble-associated prote
Keywords: 4E-BP1; eIF4E binding protein 1; 5â²-UTR; 5â²-untranslated region; AMPK; AMP-activated protein kinase; eIF; eukaryotic initiation factor; GCN2; general-control nonderepressible; GEF; guanine nucleotide exchange factor; GSK-3; glycogen synthase kinase-3;
Keywords: ECM; extracellular matrix; NF-κB; nuclear factor kappa B; Akt; protein kinase B; tPA; tissue plasminogen activator; TSRs; thrombospondin type 1 repeats; PDGF; platelet-derived growth factor; PCR; polymerase chain reaction; MCA; middle cerebral artery; CB